Skip to main content
. 2021 Jan 12;120(3):339–343. doi: 10.1097/HP.0000000000001375

Table 2.

Detailed dosimetry results.

Case # Radiopharmaceutical Effective clearance half-time (min) Mean absorbed dose to infiltrated fascia (Gy) Shallow dose equivalent to skin (Sv)
1 18F-FDG 9 0.6 0.3
2 18F-FDG 43 7.6 3.7
3 18F-FDG 93 2.7 1.3
4 18F-FDG 24 8.4 4.1
5 18F-FDG 13 0.8 0.4
6 18F-FDG 22 0.7 0.3
7 18F-FDG 44 0.9 0.4
8 18F-FDG 39 11.2 5.4
9 18F-FDG 70 1.0 0.5
10 18F-FDG 38 8.7 4.2
11 18F-FDG 22 3.8 1.9
12 18F-FDG 41 0.6 0.3
13 99mTc-MDP 360 8.4 < 0.1
14 18F-FDG 46 1.0 0.5
15 99mTc-MDP 64 1.5 < 0.1
16 99mTc-MDP 218 5.3 < 0.1
17 99mTc-MDP 38 0.9 < 0.1
18 99mTc-MDP 49 1.2 < 0.1
19 99mTc-MDP 64 1.5 < 0.1
20 18F-FDG 18 1.1 0.5
21 18F-FDG 22 5.1 2.5
22 99mTc-MDP 36 0.9 < 0.1
23 18F-FDG 24 6.8 3.3
24 18F-FDG 79 2.9 1.4
25 18F-FDG 26 0.8 0.4
26 18F-FDG 22 3.6 1.8